Navigation Links
Verdasys Introduces New Managed Service for Cyber Threat Defense
Date:5/21/2013

Waltham, Mass. (PRWEB) May 21, 2013

Verdasys today announced availability of its cloud-based Managed Service for Cyber Defense (MSCD), a fully managed, outsourced service for companies and government agencies that need to prevent increasingly sophisticated malware and persistent cyber attacks from stealing sensitive data.

MCSD leverages Verdasys' Digital Guardian data protection platform by making it available via a hosted service, extending its unique visibility into all data transactions and systems events as well as data exfiltration blocking with new capabilities for multi-layered prevention, detection, containment and investigation of targeted cyber attacks. The new managed solution provides organizations with service-based visibility and control over human and application exploit based cyber attacks, as well as visibility and containment control over the expansion, data access, manipulation and exfiltration stages of a data targeted attack. MSCD is uniquely capable of detecting and preventing cyber attacks on endpoint devices on or off the enterprise network infrastructure. Additionally, it is designed to work with a variety of next-generation firewalls, virtual and cloud-based web malware protection systems and SIEM solutions, without costly investments in technolo
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Cayman Enterprise City Introduces Referral Network
2. InVite® Health Introduces New Food-Based Dietary Supplement – Greens Hx™
3. Green Acre Aquaponics Introduces a Revolutionary Approach to Farm Education and Commercial Aquaponics
4. Beach Bum Tanning & Airbrush Salon introduces Facial & Body Masks
5. Body Mint-USA Introduces Chemical and Aluminum-Free Odor Solution Making It a Natural Deodorant Choice
6. Dissertation Writers introduces three simple steps to research support service
7. ReNew Life, America’s #1 Probiotic Brand, Introduces a High-Potency Probiotic Uniquely Formulated for Women
8. Willowbrook Area Dialysis Center Introduces Medical Directors and Staff at Open House and Family Day
9. Nueracel Introduces an All Natural Peripheral Neuropathy Treatment
10. PolyU introduces International Design and Business Management Master Programme to Develop "T-Shaped" Professionals
11. Short Dresses Shop Introduces New Prom Dresses This Year with Discounts
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... It’s very easy to become overwhelmed with ... put to the wayside until Christmas and the New Year ... “itch” and that burning desire to just escape it all ... journey to Telluride with a no-fuss, affordable package. Montrose Days ... the resort, and ensure that all accommodations are met. Plus, ...
(Date:12/19/2014)... December 19, 2014 Energy Textiles ... are now available. Celliant, the world’s leading responsive ... and pillowcases. , There are a number of ... circulation, increased oxygenation and balanced body temperature; which ... and pain relief; enhanced athletic performance; and overall ...
(Date:12/19/2014)... (PRWEB) December 19, 2014 SuperCloset raises ... SuperClone Rooms. SuperCloset continues to offer indoor growers the ... one of the new SuperClone Rooms with the award ... and turnkey indoor hydroponic grow room setup. , The ... world, SuperCloset’s SuperPonic SuperCloner 50 . ...
(Date:12/19/2014)... (PRWEB) December 20, 2014 An evening dress ... in a lady’s closet. Discount-Dress.com, a distinguished dresses retailer, has ... buy beautiful dresses in this great shopping platform. Customers ... to the staff's hard work, Discount-Dress.com has been accepted and ... a faster and easier shopping stage for clients. In order ...
(Date:12/19/2014)... FRIDAY, Dec. 19, 2014 (HealthDay News) -- New research warns parents ... young lives at risk. Nearly half of teen drivers killed ... that were at least 11 years old and often lacked important ... Eighty-two percent of teen drivers killed in crashes were in ... six to 10 years old, 31 percent were in cars 11 ...
Breaking Medicine News(10 mins):Health News:Days Inn Montrose Colorado Delivers Last Minute Holiday Season Ski Getaway Accommodations 2Health News:Energy Textiles Launches Celliant Revitalizing Bedsheets 2Health News:SuperCloset Continues to Innovate with New Complete Indoor Grow Room Packages, The SuperClone Rooms are the Newest Addition to the Award Winning SuperRoom Lineup 2Health News:Attractive Evening Dresses Announced by Discount-Dress.com 2Health News:Older Cars a Bad Choice for Younger Drivers 2
... By Steven Reinberg HealthDay Reporter , THURSDAY, ... medical groups gathered Thursday to warn of impending dangers ... speeding climate change. They believe the federal government, ... power to curtail such emissions, however. "The science ...
... New research shows that a less-toxic combination of a ... long-term remissions in some chronic lymphocytic leukemia patients. And ... therapy-related myelodysplastic syndrome and acute myeloid leukemia, which can ... these patients. The multi-institutional study, led by researchers ...
... sophisticated imaging test to probe for higher-level cognitive functioning in ... the view it presents is one that is blurred in ... the Feb. 25 online edition of the journal Brain ... in their function from minimally conscious state to the locked-in ...
... WEDNESDAY, Feb. 23 (HealthDay News) -- A new drug ... standard treatment of zoledronic acid (Zometa) for preventing fractures ... cancer, a new study suggests. In many patients, ... the first few years of diagnosis. As a result, ...
... (HealthDay News) -- A large number of dialysis patients ... radiation doses, and doctors should think about reducing these ... The researchers noted that many kidney disease patients ... that require them to undergo radiation procedures for diagnosis ...
... at Memorial Sloan-Kettering Cancer Center have found that change in ... is a poor predictor of prostate cancer and may lead ... 5,000 men was published online February 24 in the ... Associate Attending Research Methodologist in the Department of Epidemiology and ...
Cached Medicine News:Health News:Medical Groups Warn Of Climate Change's Potential Impact on Health 2Health News:Medical Groups Warn Of Climate Change's Potential Impact on Health 3Health News:Medical Groups Warn Of Climate Change's Potential Impact on Health 4Health News:Rituximab and fludarabine produce long-term remissions in CLL 2Health News:Brain imaging provides window into consciousness 2Health News:Brain imaging provides window into consciousness 3Health News:Brain imaging provides window into consciousness 4Health News:Brain imaging provides window into consciousness 5Health News:Newer Drug May Help Prevent Fracture in Men With Prostate Cancer 2Health News:Many Dialysis Patients at Risk for High Radiation Exposure 2Health News:Change in PSA level does not predict prostate cancer 2
(Date:12/19/2014)... and LYON, France , Dec. 19, ... LLY ) and Adocia (Euronext Paris: FR0011184241 – ADOC) ... an ultra-rapid insulin, known as BioChaperone Lispro, for treatment ... BioChaperone Lispro relies on Adocia,s proprietary BioChaperone® technology and ... and Adocia will develop BioChaperone Lispro with the goal ...
(Date:12/17/2014)... SAN DIEGO , Dec. 17, 2014 ... and Volcano Corporation (NASDAQ: VOLC ), a global ... today announced that they have entered into a definitive merger ... offer to acquire all of the issued and outstanding shares ... equity purchase price of USD 1 billion (approx. EUR 800 ...
(Date:12/17/2014)... December 17, 2014 Revenue and earnings ... on research and development In the past 2013/14 ... by two percent to EUR 4.287 billion (last year: EUR ... 14 percent to EUR 360 million. "Overall, 2013/14 was a ... Michael Kaschke , President and CEO of Carl Zeiss AG. ...
Breaking Medicine Technology:Lilly and Adocia Announce Alliance to Co-Develop Ultra-Rapid Insulin Based on BioChaperone Technology 2Lilly and Adocia Announce Alliance to Co-Develop Ultra-Rapid Insulin Based on BioChaperone Technology 3Philips to acquire Volcano to expand global leadership position in image-guided therapy market 2Philips to acquire Volcano to expand global leadership position in image-guided therapy market 3Philips to acquire Volcano to expand global leadership position in image-guided therapy market 4Philips to acquire Volcano to expand global leadership position in image-guided therapy market 5Philips to acquire Volcano to expand global leadership position in image-guided therapy market 6Philips to acquire Volcano to expand global leadership position in image-guided therapy market 7Philips to acquire Volcano to expand global leadership position in image-guided therapy market 8ZEISS Asserts its Position in Difficult Environment 2
... , WARSAW, Ind. , March 11 Zimmer ... in musculoskeletal care, will celebrate the 25th anniversary of the ...  The Natural Knee system offers a complete range of ...  Published clinical results show survivorship of the Natural Knee ...
... , March 11 Watson Pharmaceuticals, Inc. ... Food and Drug Administration (FDA) approval of TRELSTAR® 22.5 ... formulation of TRELSTAR®, a proven, simple and effective palliative ... launch, TRELSTAR® 22.5 mg is the first and only ...
Cached Medicine Technology:Zimmer Natural Knee Celebrates 25 Years of Excellence 2Zimmer Natural Knee Celebrates 25 Years of Excellence 3Zimmer Natural Knee Celebrates 25 Years of Excellence 4FDA Approves Watson's TRELSTAR(R) 22.5 mg, the First and Only 6-Month Intramuscular GnRH Agonist for the Palliative Treatment of Advanced Prostate Cancer 2FDA Approves Watson's TRELSTAR(R) 22.5 mg, the First and Only 6-Month Intramuscular GnRH Agonist for the Palliative Treatment of Advanced Prostate Cancer 3FDA Approves Watson's TRELSTAR(R) 22.5 mg, the First and Only 6-Month Intramuscular GnRH Agonist for the Palliative Treatment of Advanced Prostate Cancer 4FDA Approves Watson's TRELSTAR(R) 22.5 mg, the First and Only 6-Month Intramuscular GnRH Agonist for the Palliative Treatment of Advanced Prostate Cancer 5FDA Approves Watson's TRELSTAR(R) 22.5 mg, the First and Only 6-Month Intramuscular GnRH Agonist for the Palliative Treatment of Advanced Prostate Cancer 6FDA Approves Watson's TRELSTAR(R) 22.5 mg, the First and Only 6-Month Intramuscular GnRH Agonist for the Palliative Treatment of Advanced Prostate Cancer 7FDA Approves Watson's TRELSTAR(R) 22.5 mg, the First and Only 6-Month Intramuscular GnRH Agonist for the Palliative Treatment of Advanced Prostate Cancer 8
7 mm strong curved blade. Round handle....
3 mm diameter roller blade in line with handle. Curved shaft. Flat handle. 15 mm from curve to tip....
5 mm diameter blade. Angled 45 degrees. Hexagonal handle....
0.5 mm wide x 1.5 mm long. Angled 20 degrees. Octagonal handle....
Medicine Products: